Conference abstractPublished 24 Aug 2015
A retrospective analysis of serious adverse drug reactions in a tertiary care hospital
Manipal University, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Serious adverse drug reactions (ADRs) are associated with morbidity and mortality and result in financial burden to the patient and society. A retrospective observational study of serious adverse drug reactions over 1 year in a tertiary care hospital was carried out. Risk factors for serious ADRs were identified (Chi square test). Average direct cost of managing the adverse drug reaction was calculated. Of the 985 adverse drug reactions reported, 95 were serious ADRs. About 49.47% (n= 47) of patients were males and 50.53% (n=48) were females. The mean age of patients with serious ADRs was 48.63±15.59 years. Of the total hospital admissions, 0.05% was due to serious ADRs. The median duration of hospital stay due to serious adverse drug reaction was 7(4, 11) days. Hematological disorders (41.05%) were the most common serious ADRs followed by electrolyte disturbances (18.94%) and hypersensitivity reactions (13.68%).The common serious ADRs were leucopenia (15.78%), febrile neutropenia (12.63%) and hyponatraemia (11.57%). Anticancer drugs constituted the majority of the suspect drugs. Concomitant medications included anticancer drugs, antitubercular drugs, antiretrovirals, antileprotic drugs, antimicrobials, steroids and analgesics. The risk factor for developing serious ADRs was gender (females, p<0.04 versus males), coexisting disease (p< 0.001) and more than two concomitant medications (p< 0.01). The average total direct cost was Rs. 7306.91 per serious ADR. Since ADRs are associated with a wide variety of drugs and can affect any organ in the body, it is important to detect them early and have appropriate preventive strategies.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Smita Shenoy”
